Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

• Status: Completed
• Trial end date: 2016-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The true incidence and risks of intracranial hemorrhage (ICH) in patients on various antithrombotic treatments remain unknown. Here a nationwide study is conducted to investigate the risk for and incidence rates of ICH in users and non-users of various oral antithrombotic drugs in Norway between 2008 through 2014.

Hopefully, this study will contribute to a more responsible prescription pattern of antithrombotic medications.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: St. Olavs Hospital
• Collaborator: Norwegian University of Science and Technology

Criteria

Inclusion Criteria:

• hospitalization due to intracranial hemorrhage (ICH)

• residential address in Norway

Exclusion Criteria:

• Traumatic (high-energy) intracranial injury

• Parenteral antithrombotic treatment

• ICH related to tumor or vascular malformation